Bath & Body Works, Inc. (NYSE:BBWI) Receives $48.53 Consensus Target Price from Analysts

Shares of Bath & Body Works, Inc. (NYSE:BBWI) have earned a consensus rating of “Hold” from the fourteen brokerages that are currently covering the firm, Marketbeat.com reports. Eight investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $48.53.

A number of brokerages recently issued reports on BBWI. Wells Fargo & Company increased their price objective on Bath & Body Works from $42.00 to $48.00 and gave the stock an “equal weight” rating in a report on Wednesday, April 24th. Piper Sandler increased their price target on Bath & Body Works from $44.00 to $45.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 9th. Deutsche Bank Aktiengesellschaft raised their price target on Bath & Body Works from $53.00 to $57.00 in a report on Monday, June 3rd. Telsey Advisory Group reaffirmed an “outperform” rating and issued a $53.00 price objective on shares of Bath & Body Works in a report on Tuesday, June 4th. Finally, BMO Capital Markets raised their target price on shares of Bath & Body Works from $50.00 to $55.00 and gave the company an “outperform” rating in a research note on Wednesday, June 5th.

Bath & Body Works Stock Performance

Shares of BBWI opened at $37.69 on Thursday. The firm has a fifty day moving average of $45.54 and a 200-day moving average of $45.06. The company has a market cap of $8.41 billion, a price-to-earnings ratio of 9.71, a price-to-earnings-growth ratio of 1.29 and a beta of 1.85. Bath & Body Works has a 1 year low of $27.30 and a 1 year high of $52.99.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Tuesday, June 4th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.33 by $0.05. Bath & Body Works had a net margin of 11.92% and a negative return on equity of 40.00%. The firm had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $1.37 billion. During the same period last year, the firm posted $0.33 EPS. Bath & Body Works’s quarterly revenue was down .9% compared to the same quarter last year. Analysts predict that Bath & Body Works will post 3.29 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, June 21st. Stockholders of record on Friday, June 7th were given a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, June 7th. This represents a $0.80 annualized dividend and a dividend yield of 2.12%. Bath & Body Works’s dividend payout ratio (DPR) is 20.62%.

Institutional Trading of Bath & Body Works

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Front Row Advisors LLC bought a new position in shares of Bath & Body Works in the third quarter valued at $25,000. Trust Co. of Vermont acquired a new position in shares of Bath & Body Works in the 3rd quarter worth $27,000. Denali Advisors LLC acquired a new stake in shares of Bath & Body Works during the fourth quarter worth $27,000. GAMMA Investing LLC purchased a new stake in shares of Bath & Body Works during the fourth quarter valued at $27,000. Finally, Turtle Creek Wealth Advisors LLC acquired a new position in shares of Bath & Body Works in the 4th quarter valued at $35,000. 95.14% of the stock is owned by institutional investors and hedge funds.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.